The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
Santé et médecineIAOne-Off3a
Manifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 73.6%
Prévisionnistes
113
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 15 heures
Obsolète21 déc. 22, 17:45 UTC31 déc. 29, 23:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will FDA approve an “AI doctor” for primary care before 2030?
Manifold MarketsWill the FDA approve VERVE-102?
KalshiThe FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
Manifold MarketsWill the FDA approve Viagra as a treatment for Alzheimer's before 2030?
Manifold MarketsWill the FDA approve a fully autonomous robotic surgery device before 2030?
Manifold MarketsWill the FDA approve a cure for Type 1 diabetes before 2033?
KalshiRègles
The drug company will credit key steps of the discovery or steps in the treatment process to AI/ML techniques.
- The treatment must be approved before 2030 by the FDA for a condition afflicting at least 1 million people at the time, which had no previous cure, rarely goes into remission, and without treatment either significantly shortens lifespan or is considered extremely debilitating.
- Treatments may exist at the time, but this will be a complete cure with an efficacy of >50%.
- The treatment may need to be repeated if the illness recurs, but isn't needed on a continuing basis.
- Examples (not limited to):
- An incurable virus, bacterium, or parasite.
